Clinical Trial Update: Albumin Replacement Therapy in Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating albumin replacement therapy for septic shock was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Albumin

Snippet

Sponsor: Jena University Hospital | Conditions: Septic Shock | Phase 3 | Status: TERMINATED | Results posted: 2024-10-28